CEO of @Anteris $AVR. 25 years building #healthcare businesses around the world. Passionate about #medtech’s potential for people.
Minneapolis, MN
Joined February 2017
- Tweets500
- Following868
- Followers1.6K
- Likes361
Wayne Paterson retweeted
Thank you @mirvatalasnag for capturing this. Privileged to be working w/ @HEARTinMagnet on this, and excited to understand the clinical implications #DurAVR flow pattern might have. @CEOPaterson @chrismeduri @azeemlatib @bapat_savrtavr @AnterisTech @SusheelKodaliMD @SCMRorg
Excited to present to our shareholders at our AGM in Sydney tomorrow and look forward to seeing you there #proudtobeanteris#DurAVR#
Wayne Paterson retweeted
Watch this physician panel to hear Drs @MReardon19 , @chrismeduri , and @azeemlatib discuss the design of the DurAVR™ transcatheter heart valve and the paradigm-shifting hemodynamic results from the US Early Feasibility Study (EFS): anteristech.com/home.html
Further evidence that DurAVR™ the first in class biomimetic valve built on the Adapt® tissue platform is showing exceptional results due to its novel valve design and superior tissue science whilst maintaining more predictable delivery with a novel BE platform #valvedesign
#PCRLV: @azeemlatib presents insights from the first in man implant of the DurAVR biomimetic TAVI valve (@AnterisTech). He reports that the device had a favourable safety profile, and “outstanding” haemodynamic performance
Wayne Paterson retweeted
#PCRLV: @azeemlatib presents insights from the first in man implant of the DurAVR biomimetic TAVI valve (@AnterisTech). He reports that the device had a favourable safety profile, and “outstanding” haemodynamic performance
Wayne Paterson retweeted
⭐️ FIH & EFS data on DurAVR just presented by @azeemlatib #PCRLV
🎯Balloon-expandable
🎯Commissure-alignment
🎯Long coaptation length
🎯EXCELLENT Hemodynamics
@chrismeduri @AnterisTech @MonteHeart – at Greenwich, London
Wayne Paterson retweeted
Last week Stephanie Sellers presented bench testing results from the novel DurAVR™ THV at #TCT2023. DurAVR demonstrated superior hemodynamic performance in Redo-TAVR procedures. Learn more about DurAVR here: links.anteristech.com/3S0KAN…
#TAVR #TAVI #innovation #AnterisTech
Wayne Paterson retweeted
Is this aortic flow normal?
Two papers will help to understand the pathophysiological aetiology better -
academic.oup.com/ehjopen/art…
nature.com/articles/s41569-0…
Aortic flow MATTERS. 💯
Great way to end a great week. Meeting with the V2V team to discuss our unique TEER device for mitral repair.Thanks to the Anteris team for all the work that culminated in a great #TCT for #AVR #movingtheconversationforward #proudtobeanteris
Wayne Paterson retweeted
$AVR one of the unique distinguishing features of #DurAVR is the return of near perfect laminar flow. This impacts on valve durability, performance +. As > evidence emerges this will become a required expectation in valve performance. No other valve achieves this. #TAVR #TCT2023 – at Sydney, New South Wales
An insight into why aortic flow is becoming a novel therapeutic target.
In collaboration with world experts in aortic physiology. @NatureNews @NatRevCardiol @Nature
#WhyCMR #4DFlowCMR
Thanks ALL (@chrismeduri) and legendary Michael Markl!
Paper ⬇️
nature.com/articles/s41569-0…
Great week at TCT with incredible data being presented by Anteris demonstrating superior MPG's ,superior EOA's and superior DVI's to current therapies. A huge thanks to our team,Physicians and patients. We are moving the conversation forward ! #proudtobeanteris #DurAVR
Wayne Paterson retweeted
Standing room only! At #TCT2023, @chrismeduri presented the latest data from the DurAVR™ THV FIH Study. Remarkable hemodynamic results are holding steady at 6 months and 1 year post-op! More info: links.anteristech.com/3S0KAN…
#TAVR #TAVI #clinicaltrial #innovation
Great presentation today by Dr Latib on our US EFS study. Hemodynamics, EOAs, DVI results are unprecedented. #hemodynamicsmatter #valvedesignmatters #proudtobeanteris
DurAVR US EFS results presented @TCTMD by @azeemlatib today
In small annuli patients (mean 22.2):
✔️ safe, easy to use
✔️ no pacemakers
✔️ 93% no/trace, 7% mild PVL
🎯mean EOA 2.36
🎯MPG 7.8
🎯DVI 0.71
This groundbreaking, first biomimetic valve will change AS treatment
Anteris’ starts US trial for DurAVR transcatheter heart valve
medicaldevice-network.com/ne… via @MedicalTechMag
Wayne Paterson retweeted
$AVR Anteris Technologies improves US investor access with American Depository Receipt program tinyurl.com/223fagza @AnterisTech $DDF $AMEUF #AVR #DDF #AMEUF #ASX #ASXNews
Wayne Paterson retweeted
Incredible teamwork and support by a world-class SH team. We could not do this without our amazing team: @EdwinHoMD @MeiChau3 @m_assafin @AndreaScotti21 @jimmydoolittle @KaraBoothMonte and her research team
@jesusdaiyan @MonteHeart
#AnterisTech announces first patients successfully treated in #DurAVR THV US Early Feasibility Study @azeemlatib performed the cases at @MontefioreNYC
$AVR #TAVR #TAVI #Innovation #CardioTwitter #cardiology #heart #doctor #cardiac
Full Details: links.anteristech.com/3Ym60G…
Wayne Paterson retweeted
#AnterisTech announces first patients successfully treated in #DurAVR THV US Early Feasibility Study @azeemlatib performed the cases at @MontefioreNYC
$AVR #TAVR #TAVI #Innovation #CardioTwitter #cardiology #heart #doctor #cardiac
Full Details: links.anteristech.com/3Ym60G…
Wayne Paterson retweeted
#AnterisTech is pleased to announce DurAVR™ FIH abstract has been published in Heart Lung and Circulation as part of the 71st Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, 3-6 August 2023, Adelaide, Australia.
Visit: heartlungcirc.org/article/S1…
Wayne Paterson retweeted
#AnterisTech is proud to present “DurAVR™ TAVI first-in-human study confirms excellent haemodynamics to 1 year” at #CSANZ2023 #ANZET23
